Advanced Therapies Journal was first published in 2018 as pharmacogenomics and Omics technologies Journal and in 2023 reviewed for optimization and reformed to advanced therapies journal. Now ATJ is a premium home for the publication of interdisciplinary research on the next-generation of therapeutics and advanced therapies. The articles selected for the Editors' Choice are representative of the key topics that the journal publishes, including targeted drug delivery; drug discovery; cellular, genetic, and immunotherapies; personalized and precision medicines; theranostics; omics technologies, tissue engineering, pharmacology; toxicology, and highlight work done by researchers from across the globe.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Naderi Street, Unit 401,no. 2,iran, Islamic Republic Of
- Industry
- Public Health
- NAICS
-
Administration of Public Health Programs
- Website
- https://www.ATJournal.ir
- Keywords
- Calgary.
- HQ
- Tehran, Tehran
Advanced Therapies Journal Questions
Advanced Therapies Journal's website is https://www.ATJournal.ir
Advanced Therapies Journal's LinkedIn profile is https://ir.linkedin.com/company/atjournal
Advanced Therapies Journal has
2 employees.
View email and phone details for 2
employees at Advanced Therapies Journal.
Advanced Therapies Journal's industry is
Public Health
Advanced Therapies Journal's top competitors are
Mind Body Souls Network,
Institute Of Scientific Research For Precision Medicine,
Imugene Limited,
Kelly,
Royan Atitech Pharmed,
Personalized Medicine Journal,
Amr - One Health Consortium,
Drugpatents-In-The-Last-14days.
Advanced Therapies Journal's categories are Public Health
Advanced Therapies Journal's founding year is 2018
